乳腺内分泌外科スタッフの主な業績
Breast Cancer 2024 Mar;31(2;31(2):234-242.
Reliability and validity of the Japanese version of the Chemotherapy-induced Alopecia Distress Scale
Jpn J Clin Oncol. 2023 Jun 29;53(7):562-571
Effectiveness of PET/CT and VATS for detecting and treating internal mammary lymph node metastasis: A case series
Shun Kawaguchi1*, Nobuko Tamura1, Soichiro Suzuki2, Aya Nishikawa1, Akio Shibata1, Kiyo Tanaka1, Yoko Kobayashi1, Takuya Ogura1, Junichiro Sato3, Keiichi Kinowaki3, Masato Shiiba4, Makiko Ishihara4, Sakashi Fujimori2 and Hidetaka Kawabata1
Breast Cancer. 2023 Jul;30(4):637-646.
High-Accuracy Prediction of Axillary Lymph Node Metastasis in Invasive Lobular Carcinoma using Focal Cortical Thickening on Magnetic Resonance Imaging
Shun Kawaguchia*, Keiichi Kinowakib, Nobuko Tamuraa, Tomohiko Masumotoc, Aya Nishikawaa, Akio Shibataa, Kiyo Tanakaa, Yoko Kobayashia, Takuya Oguraa, Junichiro Satob and Hidetaka Kawabataa
Am J Cancer Res . 2023 Oct 15;13(10):4931-4943
IL25+ macrophages are a key determinant of treatment resistance of IL17RB+ breast cancer
Yukinori Ozaki,1,2,3 Keiichi Kinowaki,4 Hidetaka Kawabata,5 and Chie Kudo-Saito1
J Immunother Cancer. 2023 Sep;11(9):e007126. doi: 10.1136/jitc-2023-007126.
Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial).
Masuda J, Sakai H, Tsurutani J, Tanabe Y, Masuda N, Iwasa T, Takahashi M, Futamura M, Matsumoto K, Aogi K, Iwata H, Hosonaga M, Mukohara T, Yoshimura K, Imamura CK, Miura S, Yamochi T, Kawabata H, Yasojima H, Tomioka N, Yoshimura K, Takano T.
Front Oncol 2022: 12: 989650
Cells. 2022 Nov 15;11(22):3610.
Sci Rep. 2022 Jun 9;12(1):9495. doi: 10.1038/s41598-022-13601-7.
Pathol Int. 2022 Feb;72(2):96-106. doi: 10.1111/pin.13190. Epub 2021 Dec 8.
TRIM39 is a poor prognostic factor for patients with estrogen receptor-positive breast cancer and promotes cell cycle progression.
Eur J Cancer. 2022 Aug;171:193-202.
Safety and efficacy of nivolumab plus bevacizumab, paclitaxel for HER2-negative metastatic breast cancer: Primary results and biomarker data from a phase 2 trial (WJOG9917B).
Medicine (Baltimore). 2022 Dec 16;101(50):e32199. doi: 10.1097/ PMID: 36550858
Solitary fibrous tumor of male breast: A case report and literature review
Kawaguchi S, Kinowaki K, Tamura N, Nishikawa A, Shibata A, Tanaka K, Kobayashi Y, Ogura T, Sato J, Kawabata H.
Int J Mol Sci. 2021, 22, 11505. https://doi.org/10.3390/ijms222111505
OCT1 is a poor prognostic factor for breast cancer patients and promotes cell proliferation via inducing NCAPH
Takuya Ogura, Kotaro Azuma, Junichiro Sato, Keiichi Kinowaki, Ken-Ichi Takayama, Toshihiko Takeiwa, Hidetaka Kawabata, Satoshi Inoue
Breast Cancer Res Treat. 2021 Dec;190(3):425-434.
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17)
Fukada I, Ito Y, Kondo N, Ohtani S, Hattori M, Tokunaga E, Matsunami N, Mashino K, Kosaka T, Tanabe M, Yotsumoto D, Yamanouchi K, Sawaki M, Kashiwaba M, Kawabata H, Kuroi K, Morita S, Ohno S, Toi M, Masuda N.
Breast Cancer Res Treat. 2021 Jul;188(1):117-131
Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial
Norikazu Masuda, Hiroko Bando, Takashi Yamanaka, Takayuki Kadoya, Masato Takahashi, Shigenori E. Nagai, Shoichiro Ohtani, Tomoyuki Aruga, Eiji Suzuki, Yuichiro Kikawa, Hiroyuki Yasojima, Hiroi Kasai, Hiroshi Ishiguro, Hidetaka Kawabata, Satoshi Morita, Hironori Haga, Tatsuki R. Kataoka, Ryuji Uozumi, Shinji Ohno & Masakazu Toi
Pathol Int 2021 Jan;71(1):60-69
Combined A20 and tripartite motif-containing 44 as poor prognostic factors for breast cancer patients of the Japanese population
Junichiro Sato, Kotaro Azuma, Keiichi Kinowaki, Kazuhiro Ikeda, Takuya Ogura, Yutaka Takazawa , Hidetaka Kawabata, Masanobu Kitagawa, Satoshi Inoue
Clin Breast Cancer. 2021 Oct;21(5):399-407
Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer
Junichiro Sato, Kotaro Azuma Keiichi Kinowaki, Kazuhiro Ikeda, Takuya Ogura, YutakaTakazawa, Hidetaka Kawabata, Masanobu Kitagawa, Satoshi Inoue
Breast Cancer. 2021 Jul;28(4):896-903
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.
Cancer Res. 2020 Jun 1;80(11):2230-2242.
PSF promotes ER-positive breast cancer progression via posttranscriptional regulation of ESR1 and SCFD2
Yuichi Mitobe, Kaori Iino, Ken-ichi Takayama, Kazuhiro Ikeda, Takashi Suzuki, Kenjiro Aogi, Hidetaka Kawabata, Yutaka Suzuki, Kuniko Horie-Inoue and Satoshi Inoue
BMC Cancer 2020 Apr 16;20(1):325. doi: 10.1186/s12885-020-06834-0.
Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients
Yuko Tanabe; Seiji Shiraishi; Kenji Hashimoto; Kazutaka Ikeda; Daisuke Nishizawa; Junko Hasegawa; Akihiko Shimomura; Yukinori Ozaki; Nobuko Tamura; Mayu Yunokawa; Kan Yonemori; Toshimi Takano; Hidetaka Kawabata; Kenji Tamura; Yasuhiro Fujiwara; Chikako Shimizu
Cancer Sci. 2019 Nov 16. doi: 10.1111/cas.14240. [Epub ahead of print]
RNA-binding protein NONO promotes breast cancer proliferation via posttranscriptional regulation of SKP2 and E2F8
Iino, Kaori; Mitobe, Yuichi; Ikeda, Kazuhiro; Takayama, Kenichi; Suzuki, Takashi; Kawabata, Hidetaka; Suzuki, Yutaka; Horie-Inoue, Kuniko; Inoue, Satoshi
Mol Cell Biol. 2019 Nov 12;39(23). pii: e00261-19. doi: 10.1128/MCB.00261-19. Print 2019 Dec 1.
ESR1-stabilizing lncRNA TMPO-AS1 promotes hormone-refractory breast cancer progression.
Yuichi Mitobea , Kazuhiro Ikeda , Takashi Suzuki , Kiyoshi Takagi , Hidetaka Kawabata , Kuniko Horie-Inoue and Satoshi Inoue
BMC Cancer. 2019 Oct 22;19(1):980.
Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review
Momoko Takahashi, Yukinori Ozaki, Rika Kizawa, Jun Masuda, Kentaro Sakamaki, Keiichi Kinowaki, Taro Umezu, Chihiro Kondoh, Yuko Tanabe, Nobuko Tamura, Yuji Miura, Takashi Shigekawa, Hidetaka Kawabata, Noriyuki Baba, Haruo Iguchi & Toshimi Takano
Breast. 2018 Apr 23;40:67-75
A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP.
Takano T, Tsurutani J, Takahashi M, Yamanaka T, Sakai K, Ito Y, Fukuoka J, Kimura H, Kawabata H, Tamura K, Matsumoto K, Aogi K, Sato K, Nishio K, Nakagawa K, Saeki T.
Asia Pac J Clin Oncol. 2018 Mar 1. doi: 10.1111/ajco.12863
A multicenter, observational study of metastatic breast cancer patients who were treated with eribulin mesylate or taxane-based regimens.
Kikuchi Y, Uchida Y, Shirakawa K, Kanauchi H, Niwa T, Nishioka K, Tada K, Hashimoto M, Yasuda H, Sugiura R, Kawabata H, Seto Y, Ogawa T.
Breast Cancer. 2018 May;25(3):343-349
Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study.
Ozaki Y, Tanabe Y, Tamura N, Ogura T, Kondoh C, Miura Y, Yoshimura K, Kawabata H, Takano T.
Int J Mol Sci. 2017 Sep 8;18(9). pii: E1931.
Hidetaka Kawabata, Kotaro Azuma, Kazuhiro Ikeda, Ikuko Sugitani, Keiichi Kinowaki, Takeshi Fujii, Akihiko Osaki, Toshiaki Saeki, Kuniko Horie-Inoue, Satoshi Inoue
TRIM44 is a poor prognostic factor for breast cancer patients as a modulator of NF-κB signaling
Cancer Chemother Pharmacol. 2017 Jun;79(6):1179-1186
Tanabe Y, Shimizu C, Hamada A, Hashimoto K, Ikeda K, Nishizawa D, Hasegawa J, Shimomura A, Ozaki Y, Tamura N, Yamamoto H, Yunokawa M, Yonemori K, Takano T, Kawabata H, Tamura K, Fujiwara Y.
Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.
Breast Cancer Res Treat. 2014 May;145(1):143-53
Takada M, Ishiguro H, Nagai S, Ohtani S, Kawabata H, Yanagita Y, Hozumi Y, Shimizu C, Takao S, Sato N, Kosaka Y, Sagara Y, Iwata H, Ohno S, Kuroi K, Masuda N, Yamashiro H, Sugimoto M, Kondo M, Naito Y, Sasano H, Inamoto T, Morita S, Toi M.
Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study).
The Breast 2014 August 23(4) 466-72
Maki Tanioka, Masaoki Sasaki, Akihiko Shimomura, Makoto Fujishima, Mihoko Doi, Kazuo Matsuura, Toshiko Sakuma, Kenichi Yoshimura, Toshiaki Saeki, Masahiro Ohara, Junji Tsurutani,Masahiro Watatani, Toshimi Takano, Hidetaka Kawabata, Hirofumi Mukai, Yoichi Naito, Koichi Hirokaga, Shintaro Takao and Hironobu Minami
Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status
Chemotherapy 2013; 59(2):93-98
Marie Hanaoka, Hidetaka Kawabata, Tsuguo Iwatani, Toshimi Takano, Daishu Miura Reduction of Toxicity by Reversing the Order of Infusion of Docetaxel and Cyclophosphamide.
J Cancer 2013 4:519-523
Miura Y, Theriault RL, Naito Y, Suyama K, Shimomura A, Iwatani T, Miura D, Kawabata H, Kumada H, and Takano T:
The safety of chemotherapy for breast cancer patients with hepatitis C virus infection.
Psycho-Oncology 2012 (Article first published online:DOI: 10.1002/pon.3023)
Tsuguo Iwatani, Ayako Matsuda, Hidetaka Kawabata, Daishu Miura, Eisuke Matsushima
Predictive factors for psychological distress related to diagnosis of breast cancer.
J.Clin.Oncol 2011,29, e113-115
Tsuguo Iwatani, Hidetaka Kawabata, Daishu Miura, Yasunori Ota, Kenichi Ohashi
Complete Spontaneous Regression of Primary Diffuse Large B-cell Lymphoma of the Breast
N Engl J Med 2011;365:1056-7
Marie Hanaoka, Toshimi Takano, Hidetaka Kawabata (Comment on: N Engl J Med 2011; 364: 2381-2391)
Exemestane for Breast-Cancer Prevention.
Breast Cancer, 2009, DOI 10.1007/s12282-009-0149-1
Tsuguo Iwatani, Hidetaka Kawabata, Daishu Miura, Naoko Inoshita, Yasunori Ohta
Nodular fasciitis of the breast.
Lancet,2001,358,1018
Hidetaka Kawabata, Takafumi Ueno
Screening recommendation for women taking tamoxifen
Lancet 2000,355,238
Takafumi Ueno、Hidetaka Kawabata
Tobacco and health care professionals in Japan
Lancet 1999,354,1207
Hidetaka Kawabata，Takafumi Ueno
Early Lung Cancer Action Project.
Lancet 1999,353,2077
Hidetaka Kawabata，Takafumi Ueno
Controversy over cancer chemotherapy in Japan
